Abstract
Bisfuranoid mycotoxins are a family of fungal metabolites that contain in their molecules a characteristic dihydrobisfuran ring structure. Some representative bisfuranoid mycotoxins are aflatoxins B1, Gl, M1, sterigmatocystin, O- methylsterigmatocystin, and versicolorin A (See Figure 1 & 2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baertschi, S. W., Raney, K. D., Stone, M. P., and Harris, T. M. (1988). Preparation of the 8,9-epoxide of the mycotoxin aflatoxin Bp the ultimate carcinogenic species. J. Am. Chem. Soc. 110, 7929–7931.
Beasley, R. P., and Hwang, L. (1984). Epidemiology of hepatocellular carcinoma. In Viral Hepatitis and Liver Disease ( G. N. Vyas, J. L. Dienstag, and J. H. Hoffnagle, eds.), pp. 209–224. New York: Grune & Stratton.
Bechtel, D. H. (1989). Molecular dosimetry of hepatic aflatoxin BI-DNA adducts: linear correlation with hepatic cancer risk. Regul. Toxicol. Pharmacol. 10, 7481.
Buss, P. and Lutz, W. K. (1988). Steady-state DNA adduct level in rat liver after chronic exposure to low doses of aflatoxin Bi and 2-acetylaminofluorine. Abstract. Proc. Amer. Assoc. Cancer Res. 29, 380.
Cole, R. J., and Cox, R. H. (1981). Handbook of Toxic Fungal Metabolites. New York: Academic Press.
Croy, R. G. and Wogan, G. N. (1981). Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin Bi. Cancer Res. 41, 197–203.
Essigmann, J. M., Croy, R. G., Bennett, R. A., and Wogan, G. N. (1982). Metabolic activation of aflatoxin Bi: patterns of DNA adduct formation, removal, and excretions in relation to carcinogenesis. Drug Metab. Rev. 13, 581–602.
Essigmann, J. M., Croy, R. G., Nadzan, A. M., Busby, W. F., Reinhold, V. N., Buchi, G., and Wogan, G. N. (1977). Structural identification of the major DNA adduct formed by aflatoxin Bi in vitro. Proc. Natl. Acad. Sci. USA 74, 1870–1874.
Foster, P. L., Eisenstadt, E., and Miller, J. H. (1983). Base substitution mutations induced by metabolically activated AFB1. Proc. Natl. Acad. USA 80, 2695–2698.
Gan, S., Skipper, P. L., Peng, X., Groopman, J. D., Chen, J., Wogan, G. N., and Tannenbaum, S. R. (1988). Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin Bi intake and urinary excretion of aflatoxin Mi. Carcinogenesis 9, 1323–1325.
Garner, R. C., Dvorackova, I., and Tursi, F. (1988). Immunoassay procedures to detect exposure to aflatoxin Bi and benzo(a)pyrene in animals and man at the DNA level. Int. Arch. Occup. Environ. Health 60, 145–150.
Hendricks J.D., Sinnhuber R.O., Wales J.H., Stack M.E., and Hsieh D.P.H. (1980). Hepatocarcinogenicity of sterigmatocystin and versicolorin A to rainbow trout (Salmo gairdneri) embryos. J. Natl. Cancer Inst. 64, 1503–1509.
Hsieh, D. P. H., Wan, C. C., and Billington, J. A. (1989). A versiconal hemiacetal acetate converting enzyme in aflatoxin biosynthesis. Mycopathologia 107, 121–126.
Hsieh, D. P. H., Wong, Z. A., Wong, J. J., Michas, C., and Ruebner, B. H. (1977). Comparative metabolism of aflatoxin. In Mycotoxins in Human and Animal Health (J. V. Rodricks, C. W. Hesseltine, and M. A. Mehlman, Ed.). pp. 37–50. Park Forest South, IL: Pathotox Publishers.
Hsieh, L., Hsu, S., Chen, D., and Santella, R. M. (1988). Immunological detection of aflatoxin Bi-DNA adducts formed in vivo. Cancer Res. 48, 6328–6331.
IARC. (1987a). IARC monographs on the evaluation of carcinogenic risks to humans–overall evaluations of carcinogenicity: an updating of IARC Monographs volumes to 42. Suppl. 7, 56–75.
IARC. (1987b). IARC monographs on the evaluation of carcinogenic risks to humans–overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. Suppl. 7, 82–87.
Irvin, T. R., and Wogan, G. N. (1984). Quantitation of aflatoxin Bi adduction within the ribosomal RNA gene sequences of rat liver DNA. Proc. Natl. Acad. Sci. USA 81, 664–668.
Lin, J., Miller, J. A., and Miller, E. C. (1977). 2, 3-Dihydro-2-(guan-7-yl)-3-hydroxyaflatoxin Bi, a major acid hydrolysis product of aflatoxin Bi-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res. 37 4430–4438.
Loechler, E. L., Teeter, M. M., and Whitlow, M. D. (1988). Mapping the binding site of aflatoxin Bi in DNA: molecular modeling of the binding sites for the N(7)-guanine adduct of aflatoxin Bi in different DNA sequences. J. Biomol. Struct. Dyn. 5, 1237–1257.
Lutz, W. K. (1987). Quantitative evaluation of DNA-binding data in vivo for low-dose extrapolations. Arch. Toxicol. Suppl. 11, 66–74.
Martin, C. N., and Garner, R. C. (1977). Aflatoxin B-oxide generated by chemical or enzymic oxidation of aflatoxin Bi causes guanine substitution in nucleic acids. Nature 267, 863–865.
Modali, R. and Yang, S. S. (1986). Specificity of aflatoxin Bi binding on human proto-oncogene nucleotide sequence. In Monitoring of Occupational Genotoxicants ( M. Sorsa and H. Norppa, ed.), pp. 147–158. Alan R. Liss.
Niranjan, B. G., Bhat, N. K., and Avadhani, N. G. (1982). Preferential attack of mitochondrial DNA by aflatoxin Bi during hepato-carcinogenesis. Science 215, 73–75.
Peers, F., Bosch, X., Kaldor, J., Linsell, A., and Pluumen, M. (1987). Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int. J. Cancer 39, 545–553.
Pohland, A. E. and Wood, G. E. (1987). Occurrence of mycotoxins in food. In Mycotoxins in Food ( P. Krogh, ed.), pp. 35–64. London: Academic Press.
Reddy, M. B., Irvin, T. R., and Randerath, K. (1985). Formation and persistence of sterigmatocystin-DNA adducts in rat liver determined via 32P-postlabeling analysis. Mutat. Res. 152, 85–96.
Sabbioni, G., Skipper, P. L., Buchi, G., and Tannenbaum, S. R. (1987). Isolation and characterization of the major serum albumin adduct formed by aflatoxin Bi in vivo in rats. Carcinogenesis 8, 819–824.
Schaaper, R. M., Kunkel, T. A., and Loeb, L. A. (1983). Infidelity of DNA synthesis associated with bypass of apurinic sites. Proc. Natl. Acad. Sci. USA 80, 487–491.
Shimada, T., and Guengerich, F. P. (1989). Evidence for cytochrome P-45ONF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Nat/. Acad. Sci. USA 86, 462–465.
Shimada, T., Nakamura, S., Imaoka, S., and Funae, Y. (1987). Genotoxic and mutagenic activation of aflatoxin Bi by constitutive forms of cytochrome P-450 in rat liver microsomes. Toxicol. Appl. Pharmacol. 91, 13–21.
Sun, T. and Chu, Y. (1984). Carcinogenesis and prevention strategy of liver cancer in areas of prevalence. J. Cell Physiol. Supp/. 3, 39–44.
Swenson D.H., Miller J.A., and Miller E.C. (1975). The reactivity and carcinogenicity of aflatoxin Bi-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin Bi. Cancer Res. 35, 3811–3823.
Takayama, K., Wakabayashi, K. L., Hsieh, D. P. H., Sugimura, T., and Nagao, M. (1989). Detection of aflatoxin-DNA adducts in liver of humans in Taiwan and Japan. Abstract. The 1989 International Chemical Congress of Pacific Basin Societies, Honolulu, Hawaii, December, 1989.
Ueno Y., Ishii K., Omata Y., Kamataki T., and Kato R. (1983). Specificity of hepatic cytochrome P-450 isoenzymes from PCB-treated rats and participation of cytochrome b5 in the activation of aflatoxin Bi. Carcinogenesis 4, 1071–1077.
Van Rensburg, S. J., Cook-Mozaffari, P., Van Schakkwyk, D. J., Van Der Watt, J. J., Vincent, T. J., and Purchase, I. F. (1985). Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer 51, 713–726.
Wogan, G. N. (1989). Molecular and cellular events associated with aflatoxin-induced hepatocarcinogenesis. Pure Appl. Chem. 61, 1–6.
Wong J.J. and Hsieh D.P.H. (1976). Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential. Proc. Natl. Acad. Sci. USA 73, 2241–2244.
Wong J.J., Singh R., and Hsieh D.P.H. (1977). Mutagenicity of fungal metabolites related to aflatoxin biosynthesis. Mutat. Res. 44, 447–450.
Yang, S. S., Taub, J. V., Modsli, R., Vieira, W., Yasei, P., and Yang, G. C. (1985). Dose dependency of aflatoxin Bi binding on human high molecular weight DNA in the activation of Proto-Oncogene. Environ. Health Perspect. 62, 231–238.
Yu, F. (1983). Preferential binding of aflatoxin Bi to the transcriptionally active regions of rat liver nucleolar chromatin in vivo and in vitro. Carcinogenesis 4, 889–893.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Hsieh, D.P.H., Atkinson, D.N. (1991). Bisfuranoid Mycotoxins: Their Genotoxicity and Carcinogenicity. In: Witmer, C.M., Snyder, R.R., Jollow, D.J., Kalf, G.F., Kocsis, J.J., Sipes, I.G. (eds) Biological Reactive Intermediates IV. Advances in Experimental Medicine and Biology, vol 283. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5877-0_69
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5877-0_69
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5879-4
Online ISBN: 978-1-4684-5877-0
eBook Packages: Springer Book Archive